Skip to main content

International Journal of Hematology

Ausgabe 6/2012

Inhalt (26 Artikel)

In Memoriam

E. Donnall Thomas (1920–2012)

Robert Peter Gale

In Memoriam

Dr. E. Donnall Thomas

Shinichiro Okamoto

Images in Hematology

Subacute methotrexate-related leukoencephalopathy with stroke-like presentation

Kayoko Iwatani, Nobuharu Fujii, Shoko Deguchi, Mitsune Tanimoto

Original Article

Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice

Yusuke Sasaki, Mariko Noguchi-Sasaki, Hideyuki Yasuno, Keigo Yorozu, Yasushi Shimonaka

Original Article

Acidic milieu augments the expression of hepcidin, the central regulator of iron homeostasis

Chisaki Mizumoto, Hiroshi Kawabata, Tatsuki Uchiyama, Soichiro Sakamoto, Junya Kanda, Naohisa Tomosugi, Akifumi Takaori-Kondo

Original Article

Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin

Cong Ma, Yuxiao Zhang, Qiang Xu, Jie Yang, Yan Zhang, Lei Gao, Bin Xu, Hongjuan Wang, Yang Li, Caiyi Lu, Tong Yin

Original Article

Platelets with a W127X mutation in GPIX express sufficient residual amounts of GPIbα to support adhesion to von Willebrand factor and collagen

Yuka Takata, Taisuke Kanaji, Masaaki Moroi, Ritsuko Seki, Masayuki Sano, Sachie Nakazato, Eisaburo Sueoka, Yutaka Imamura, Takashi Okamura

Original Article

Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy

Brian McLaughlin, Annie Im, Anastasios Raptis, Mounzer Agha, Jing-Zhou Hou, Robert Redner, Shrina Duggal, Yan Lin, Clay Smith, Michael Boyiadzis

Original Article

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

Mitsutoshi Kurosawa, Masakatsu Yonezumi, Satoshi Hashino, Junji Tanaka, Mitsufumi Nishio, Makoto Kaneda, Shuichi Ota, Kyuhei Koda, Nobuhiro Suzuki, Makoto Yoshida, Yasuo Hirayama, Rishu Takimoto, Yoshihiro Torimoto, Akio Mori, Tohru Takahashi, Susumu Iizuka, Tadao Ishida, Ryoji Kobayashi, Takanori Oda, Hajime Sakai, Satoshi Yamamoto, Fumihiko Takahashi, Takashi Fukuhara

Original Article

Itraconazole may increase the risk of early-onset bortezomib-induced peripheral neuropathy

Norisato Hashimoto, Kenji Yokoyama, Ken Sadahira, Tomoki Ueda, Yuiko Tsukada, Shinichiro Okamoto

Original Article

Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis

Wei Liu, Han-Yun Ren, Yu-Jun Dong, Li-Hong Wang, Yue Yin, Yuan Li, Zhi-Xiang Qiu, Xi-Nan Cen, Yong-Jin Shi

Original Article

Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin

Kazuo Hatanaka, Shigeo Fuji, Kazuhiro Ikegame, Ruri Kato, Atsushi Wake, Michihiro Hidaka, Toshiro Ito, Masami Inoue, Yoshihisa Nagatoshi, Akiyoshi Takami, Naokuni Uike, Hisashi Sakamaki, Hiromasa Yabe, Yasuo Morishima, Ritsuro Suzuki, Yoshiko Atsuta, Takahiro Fukuda

Case Report

Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis

Masatake Matsuoka, Tokifumi Majima, Tomohiro Onodera, Masahiro Ieko, Masayoshi Souri, Akitada Ichinose, Takashi Kurita, Yasuhiko Kasahara, Masahiro Inoue, Daisuke Takahashi

Case Report

Combined factor V and VIII deficiency and pregnancy

Bouchra Oukkache, Omar El Graoui, Saadia Zafad

Case Report

Two newborn-onset patients of Upshaw–Schulman syndrome with distinct subsequent clinical courses

Saori Tanabe, Hideo Yagi, Toshiyuki Kimura, Ayami Isonishi, Seiji Kato, Yoko Yoshida, Masaki Hayakawa, Masanori Matsumoto, Shinsuke Ohtaki, Yukihiro Takahashi, Yoshihiro Fujimura

Case Report

A tetraploid minimally differentiated acute myeloblastic leukemia with extensive erythrophagocytosis: a case report and literature review

Li Li, Jianlan Li, Guoxia Li, Yanhong Tan, Xiuhua Chen, Fanggang Ren, Haixiu Guo, Hongwei Wang

Case Report

Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient

Dandan Liu, Suning Chen, Jinlan Pan, Mingqing Zhu, Ni Wu, Feng Zhu, Zixing Chen

Case Report

Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea

Vikas Dua, Satya Prakash Yadav, Vijay Kumar, Renu Saxena, Anupam Sachdeva

Case Report

p210BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16)

Hai-ping Dai, Yong-quan Xue, Li–li Wu, Jin-lan Pan, Yan-lei Gong, Ya-fang Wu, Jun Zhang, De-pei Wu, Su-ning Chen

Letter to the Editor

Severe bone marrow failure associated with human parvovirus B19 infection in a case with no underlying disorder

Chihiro Kawakami, Yukako Kono, Akiko Inoue, Kimitaka Takitani, Takayuki Ikemoto, Hiroshi Tamai

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.